The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age35-90
SponsorYang ji

About this trial

To determine whether there is statisstical difference in FosB (FBJ murine osteosarcoma viral oncogene homolog B) protein expression between laryngeal cancer tissue and adjacent tissue through immunohistochemistry methods.

If there are differences, further the investigators will collect relevant patients information,such as clinical stages, pathological types, clinical prognosis and so on. ultimately analyze whether it is related to the expression of FOsB in laryngeal cancer tissue and adjacent tissues

Eligibility criteria

Qualifiers

laryngeal squamous cell carcinoma was diagnosed ,and biopsy was confirmed by two pathologists;

Primary tumor of Laryngeal ,and there was no distant metastasis;

Standard treatment such as surgery and Preliminarily-diagnosed parients;

full clinical and pathological data information and good follow-up;

Disqualifiers

Secondary cancer or cancer with distant metastasis;

Patients who have not seen a doctor for the first time or have received surgery or radiotherapy or chemotherapy in other hospitals;

Clinical and pathological data were missing and loss to follow-up;

Patients who abandoned treatment or standard treatment procedures has not been completed;

Trial design

Treatments tested in this trial

  • the expression negative in laryngeal cancer tissue
  • the expression positive in laryngeal cancer tissue

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yang ji

Lead sponsor

Neijiang No.2 People's Hospital

Sponsor institution